The FDA has accepted for review the sBLA for subcutaneous lecanemab-irmb as a weekly starting dose for Alzheimer disease.

Fresh data from multiple studies suggest the drug, which Sanofi has billed as a future blockbuster, could be cleared in the U ...

That's another key reason Zoetis could make a comeback in 2026. Regeneron had been facing stiff competition for one of its ...

Mounjaro (tirzepatide) is prescribed to manage blood sugar levels in people with type 2 diabetes. It’s available as a single-dose prefilled pen. You will administer your Mounjaro injections into your ...

In the trial, zumilokibart demonstrated: The only treatment-emergent adverse event (TEAE) observed in more than one patient was gastroesophageal reflux disease (GERD; 2 patients). There were no Grade ...

Overdose prevention sites and supervised consumption sites in Toronto are not associated with long-term increases in local crime, McGill University researchers have found. Over 10 years, crime reports ...

Regeneron shares are up 41% in six months as FDA approvals, strong Dupixent profits and oncology gains lift investor confidence.

People rest and take advantage of services at the overdose prevention center at OnPoint NYC in New York, N.Y., Friday, Feb. 18, 2022. Also known as a safe injection site, the privately run center is ...

A 40-year-old woman with type 1 diabetes mellitus (T1DM) who injected insulin into her abdomen developed a firm subcutaneous mass in the right lower quadrant. Pathology after surgical excision showed ...

The city’s two government-funded safe injection sites transported at least 46 people by ambulance to hospitals for cardiac arrest, life-threatening strokes or seizures, the New York Post reported.

Three drugs treating chronic conditions are set for Food and Drug Administration review by the end of the year, and a new report from Optum Rx digs into why payers should be watching these decisions.

Regeneron Pharmaceuticals and Sanofi have won European Commission expanded approval of their blockbuster anti-inflammatory drug Dupixent for certain patients with the inflammatory skin condition ...